Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SGRY
SGRY logo

SGRY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
14.540
Open
14.310
VWAP
14.37
Vol
1.26M
Mkt Cap
1.89B
Low
14.140
Amount
18.15M
EV/EBITDA(TTM)
10.72
Total Shares
130.79M
EV
7.21B
EV/OCF(TTM)
25.76
P/S(TTM)
0.55
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals.
Show More

Events Timeline

(ET)
2026-05-05
16:40:00
Major U.S. Averages Close Broadly Higher, Nasdaq Up 1.03%
select
2026-05-05
12:10:00
Major Averages Broadly Higher, Nasdaq Up 1%
select
2026-05-05
08:10:00
Company Reports Q1 Revenue of $810.9M, Beating Expectations
select
2026-05-05
08:10:00
Company Reaffirms FY26 Adjusted EBITDA View at Least $530M
select

News

seekingalpha
9.5
05-05seekingalpha
Surgery Partners Q1 2026 Earnings Call Insights
  • Stable Revenue Performance: In Q1 2026, Surgery Partners reported approximately $811 million in net revenue with a 4.4% year-over-year growth, indicating a gradual recovery and stabilization of operations following pressures experienced at the end of 2025.
  • EBITDA and Margin: The adjusted EBITDA for the quarter was $102 million, resulting in an EBITDA margin of 12.6%, aligning with expectations for the seasonally lower first quarter, which reflects progress in cost management and operational efficiency.
  • Investment in Surgical Robots: The company operates 73 surgical robots, contributing to a 14.6% year-over-year growth in total joints performed, which not only enhances service capabilities but also strengthens its competitive position in a challenging market.
  • Future Outlook and Acquisition Plans: Management reiterated full-year 2026 revenue guidance of $3.35 billion to $3.45 billion while actively pursuing a key acquisition opportunity in a larger surgical hospital market, expected to be announced in mid-2026, demonstrating confidence in future growth prospects.
NASDAQ.COM
2.0
05-05NASDAQ.COM
Surgery Partners SGRY Q1 2026 Earnings Transcript
seekingalpha
9.5
05-05seekingalpha
Surgery Partners Q1 Earnings Beat Expectations with Revenue Growth
  • Revenue Growth: Surgery Partners reported Q1 revenue of $810.9 million, reflecting a 4.5% year-over-year increase, exceeding market expectations by $12.97 million, indicating the company's sustained growth potential in the healthcare sector.
  • Same-Facility Metrics: Same-facility revenues rose by 4.4%, while same-facility cases increased by 0.6%, demonstrating the company's ability to expand its business steadily on existing operations, thereby enhancing its competitive position in the market.
  • Net Loss Overview: The company recorded a net loss of $35.9 million for Q1; however, adjusted EBITDA reached $102.3 million, reflecting improvements in cost control and operational efficiency despite ongoing losses.
  • 2026 Guidance: Surgery Partners reaffirmed its full-year 2026 revenue guidance to be between $3.35 billion and $3.45 billion, with adjusted EBITDA of at least $530 million, showcasing management's confidence in future growth and the stability of its strategic planning.
seekingalpha
9.5
05-04seekingalpha
Surgery Partners Set to Announce Q1 Earnings with Mixed Estimates
  • Earnings Announcement: Surgery Partners (SGRY) is set to release its Q1 2023 earnings on May 5 before market open, with consensus EPS estimate at -$0.14, reflecting a 53.3% year-over-year improvement, indicating potential recovery in profitability.
  • Revenue Expectations: The revenue estimate stands at $797.93 million, representing a 2.8% year-over-year growth, despite downward revisions, showcasing the company's resilience in the healthcare sector.
  • Historical Performance: Over the past two years, SGRY has beaten EPS and revenue estimates 63% of the time, demonstrating consistency in financial performance and maintaining market confidence.
  • Future Projections: Surgery Partners has outlined a revenue target of $3.35 billion to $3.45 billion for 2026, indicating a commitment to long-term growth strategies while advancing portfolio optimization.
Newsfilter
9.5
04-17Newsfilter
Surgery Partners to Release Q1 2026 Results and Host Conference Call
  • Earnings Release Schedule: Surgery Partners plans to announce its Q1 2026 financial results before the market opens on May 5, 2026, which is expected to provide investors with insights into the company's operational status and financial performance, aiding market analysis of future growth potential.
  • Conference Call Details: The company will host a conference call at 8:30 a.m. Eastern Time, allowing investors to participate by dialing 1-877-451-6152 domestically or 1-201-389-0879 internationally, ensuring transparency and enhancing communication with stakeholders.
  • Replay Information: A replay of the conference call will be available three hours after the call and until May 19, 2026, with domestic and international numbers being 1-844-512-2921 and 1-412-317-6671 respectively, facilitating access for investors who could not attend live.
  • Company Background: Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners operates over 200 healthcare service locations across 30 states, focusing on high-quality, cost-effective surgical and ancillary care solutions, highlighting its significant position in the rapidly growing healthcare services market.
Newsfilter
9.5
04-01Newsfilter
Surgery Partners Reports 4.2% Decline in Q4 Adjusted EBITDA
  • Financial Performance Discrepancy: Surgery Partners reported an Adjusted EBITDA of $136.4 million for Q4 2025, reflecting a 4.2% decline compared to the previous year, starkly contrasting with management's prior guidance of margin expansion, leading to a significant drop in stock price and raising concerns about financial transparency among investors.
  • Market Reaction: Despite management highlighting a 6.1% growth and a 16.6% margin in Q3, the failure to meet expectations in Q4 resulted in a sharp decline in SGRY shares, indicating a weakened market confidence in the company's future profitability.
  • Legal Investigation: Levi & Korsinsky, LLP is investigating potential securities law violations due to the significant discrepancies in financial reporting, encouraging affected shareholders to submit their information to protect their legal rights, which underscores investor concerns regarding corporate governance.
  • Investor Losses: Affected shareholders are urged to contact legal counsel for potential compensation, reflecting a crisis of trust in the company's financial reporting and investor relations, which may negatively impact future financing and market performance.
Wall Street analysts forecast SGRY stock price to rise
11 Analyst Rating
Wall Street analysts forecast SGRY stock price to rise
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
18.00
Averages
26.30
High
36.00
Current: 0.000
sliders
Low
18.00
Averages
26.30
High
36.00
Jefferies
Buy
maintain
$15 -> $17
AI Analysis
2026-05-06
New
Reason
Jefferies
Price Target
$15 -> $17
AI Analysis
2026-05-06
New
maintain
Buy
Reason
Jefferies raised the firm's price target on Surgery Partners to $17 from $15 and keeps a Buy rating on the shares. The firm says the company had a good Q1, particularly given the weather-related headwinds that affected most health-care services providers. Payor mix issues that emerged last quarter moderated in Q1 and should gradually improve over the course of the year, Jefferies argues.
Jefferies
Buy
downgrade
$15
2026-04-20
Reason
Jefferies
Price Target
$15
2026-04-20
downgrade
Buy
Reason
Jefferies lowered the firm's price target on Surgery Partners to $15 from $16.25 and keeps a Buy rating on the shares. The relative underperformance of healthcare services stocks highlights concerns among investors about Q1 volumes, notes the analyst, who is "unsure if Street numbers adequately reflect" drags from ice storms in Southern states and snow storms in the East Coast that impacted volumes.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SGRY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Surgery Partners Inc (SGRY.O) is 41.84, compared to its 5-year average forward P/E of -307.19. For a more detailed relative valuation and DCF analysis to assess Surgery Partners Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-307.19
Current PE
41.84
Overvalued PE
1309.26
Undervalued PE
-1923.65

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
17.01
Current EV/EBITDA
10.39
Overvalued EV/EBITDA
21.65
Undervalued EV/EBITDA
12.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.21
Current PS
0.52
Overvalued PS
1.64
Undervalued PS
0.78

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks bullish for the next three months
Intellectia · 83 candidates
Region: USRelative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA60One Week Predict Return: >= 0.0%One Month Rise Prob: >= 50One Month Predict Return: >= 0.0%Macd: bullish, positive
Ticker
Name
Market Cap$
top bottom
GSBD logo
GSBD
Goldman Sachs BDC Inc
1.14B
MRAM logo
MRAM
Everspin Technologies Inc
503.89M
MTRX logo
MTRX
Matrix Service Co
380.30M
AUDC logo
AUDC
AudioCodes Ltd
263.27M
GTX logo
GTX
Garrett Motion Inc
4.84B
BRAG logo
BRAG
Bragg Gaming Group Inc
51.66M
market movers ready to brakeout
Intellectia · 14 candidates
Rsi Category: moderateRelative Vol: >= 1.80Week Price Change Pct: $3.00 - $15.00Support Resistance Relationship: PriceAroundResistance, PriceAroundUpperBollMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
NTLA logo
NTLA
Intellia Therapeutics Inc
1.82B
POET logo
POET
POET Technologies Inc
1.06B
NTR logo
NTR
Nutrien Ltd
36.44B
AMBP logo
AMBP
Ardagh Metal Packaging SA
2.90B
SGRY logo
SGRY
Surgery Partners Inc
2.05B
ALMU logo
ALMU
Aeluma Inc
347.27M
create a small cap screener
Intellectia · 1387 candidates
Market Cap Category: small
Ticker
Name
Market Cap$
top bottom
SGRY logo
SGRY
Surgery Partners Inc
2.00B
QDEL logo
QDEL
QuidelOrtho Corp
2.00B
NESR logo
NESR
National Energy Services Reunited Corp
2.00B
DXPE logo
DXPE
DXP Enterprises Inc
2.00B
SKWD logo
SKWD
Skyward Specialty Insurance Group Inc
2.00B
NTCT logo
NTCT
Netscout Systems Inc
2.00B
small cap stocks $20 and under
Intellectia · 870 candidates
Price: <= $20.00Market Cap Category: small
Ticker
Name
Market Cap$
top bottom
NESR logo
NESR
National Energy Services Reunited Corp
2.00B
SGRY logo
SGRY
Surgery Partners Inc
2.00B
FMC logo
FMC
FMC Corp
1.99B
HLMN logo
HLMN
Hillman Solutions Corp
1.96B
SBET logo
SBET
SharpLink Gaming Inc
1.96B
RNW logo
RNW
Renew Energy Global PLC
1.95B

Whales Holding SGRY

D
Davidson Kempner Capital Management LP
Holding
SGRY
+100.96%
3M Return
G
Glenview Capital Management, LLC
Holding
SGRY
+12.30%
3M Return
J
Jaunty Global Limited
Holding
SGRY
+9.98%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Surgery Partners Inc (SGRY) stock price today?

The current price of SGRY is 14.44 USD — it has increased 0.91

What is Surgery Partners Inc (SGRY)'s business?

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals.

What is the price predicton of SGRY Stock?

Wall Street analysts forecast SGRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGRY is26.30 USD with a low forecast of 18.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Surgery Partners Inc (SGRY)'s revenue for the last quarter?

Surgery Partners Inc revenue for the last quarter amounts to 810.90M USD, increased 4.50

What is Surgery Partners Inc (SGRY)'s earnings per share (EPS) for the last quarter?

Surgery Partners Inc. EPS for the last quarter amounts to -0.28 USD, decreased -6.67

How many employees does Surgery Partners Inc (SGRY). have?

Surgery Partners Inc (SGRY) has 16000 emplpoyees as of May 11 2026.

What is Surgery Partners Inc (SGRY) market cap?

Today SGRY has the market capitalization of 1.89B USD.